Entrada Therapeutics Inc (TRDA)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Total Assets | 295.92M | 274.46M | 252.06M | 475.57M | 493.98M | 485.03M | 469.19M | 510.84M |
Total Current Assets | 253.9M | 234.73M | 209.88M | 434.14M | 390.2M | 383.04M | 369.77M | 414.17M |
Cash and Equivalents | 90.87M | 53.31M | 45.16M | 227.65M | 79.74M | 51.88M | 67.6M | 68.44M |
Total Non-Current Assets | 49.8M | 47.17M | 49.86M | 50.83M | 114.81M | 113.03M | 110.61M | 107.67M |
Total Liabilities | 39.88M | 41.24M | 39.5M | 245.96M | 287.08M | 238.37M | 226.83M | 241.48M |
Total Current Liabilities | 18.08M | 21.55M | 21.97M | 147.59M | 125.94M | 165.43M | 158.8M | 173.94M |
Total Non-Current Liabilities | 21.8M | 19.69M | 17.53M | 98.36M | 161.14M | 72.94M | 68.04M | 67.54M |
Common Equity | 3k | 3k | 3k | 3k | 3k | 3k | 3k | 3k |
Retained Earnings | -138.52M | -163.66M | -188.29M | -194.96M | -220.89M | -185.43M | -194.97M | -171.47M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 305.83M | 252.06M | 469.19M |
Total Current Assets | 298.7M | 209.88M | 369.77M |
Cash and Equivalents | 291.06M | 45.16M | 67.6M |
Total Non-Current Assets | 298.72M | 212.55M | 242.36M |
Total Liabilities | 7.12M | 39.5M | 226.83M |
Total Current Liabilities | 6.72M | 21.97M | 158.8M |
Total Non-Current Liabilities | 396k | 17.53M | 68.04M |
Total Equity | 298.72M | 212.55M | 242.36M |
Common Equity | 3k | 3k | 3k |
Retained Earnings | -93.67M | -188.29M | -194.97M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.